| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 09/24/2008 | EP1972626A2 Process for producing scopine esters |
| 09/24/2008 | EP1971608A1 Spiroketals |
| 09/24/2008 | EP1971599A1 Antiviral 2-carboxy-thiophene compounds |
| 09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/24/2008 | CN101273046A Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 09/24/2008 | CN101270123A 20(S)-camptothecinum and method for preparing analogue |
| 09/24/2008 | CN101270122A Amino acid norcantharidin acid imide derivative with optical activity and preparation method thereof |
| 09/24/2008 | CN101270121A Rhodamine 6G hydrazide salicylaldehyde azomethine, synthesizing process and application in measuring content of copper ion |
| 09/24/2008 | CN101270087A Isoquinoline derivatives and methods of use thereof |
| 09/23/2008 | US7427682 Indole derivatives as selective androgen receptor modulators (SARMS) |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427630 1-{1-[1-(4-Methoxy-2-methylphenyl)-6-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl]-1H-pyrazol-3-yl}imidazolidin-2-one; potent; to treat central nervous system disorders; antidepressants; Anxiolytic agents; mood disorders; anagesics; gastrointestinal disorders like irritable bowel syndrome |
| 09/23/2008 | US7427625 Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427616 e.g. 8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine9-methyl-8-(1-methyl-4-phenyl-1H-imidazol-5-yl)-9H-purin-6-amine; Tie2 receptor tyrosine kinase and angiogenesis inhibitor; diabetic retinopathy, psoriasis, cancer, rheumatoid arthritis, atheroma, Kaposi's sarcoma and haemangioma |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/18/2008 | WO2008110611A1 Organic compounds and their uses |
| 09/18/2008 | WO2007123995A3 Camptothecin-analog with a novel, “flipped” lactone-stable, e-ring and methods for making and using same |
| 09/18/2008 | US20080227982 Solvent free amorphous rapamycin |
| 09/18/2008 | US20080227804 Polymorphic solvates of naltrexone with ethanol, benzyl alcohol, dimethylformamide, methanol, dichloromethane, acetone and hexane; sustained release formulations |
| 09/18/2008 | US20080227803 relieving and/or preventing side effects induced by a compound having opioid receptor agonism |
| 09/18/2008 | US20080227793 2-(1-Imidazomethyl)- or 2-(1-imidazooxy)-substituted, e.g., 6-chloro-2-{[2-(2-fluorophenyl)-1H-imidazol-1-yl]methyl}-1-propyl1H-benzimidazole; GABA receptor signal transduction; anxiety, antidepressants, sleep disorders, schizophrenia, attention deficit-hyperactivity disorder, memory enhancement |
| 09/18/2008 | US20080227785 BEC 1 potassium channel inhibitors, used to treat dementia and learning disorders; e.g., N-(4-fluorophenyl)-N'-isopropyl-N''-phenyl-1,3,5-triazine-2,4,6-triamine hydrochloride |
| 09/18/2008 | US20080227684 Small Molecule Inhibitors of PDZ Interactions |
| 09/18/2008 | US20080226747 Cell proliferation; anticancer agents; bioavailability |
| 09/18/2008 | US20080226674 Anticancer drugs encapsulated in and mixed with envelop protein virus vector; intensify immunology response in animals |
| 09/18/2008 | US20080226591 Compounds for the Treatment of Hepatitis C |
| 09/18/2008 | DE102007009235A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives |
| 09/18/2008 | CA2681162A1 Benzyl and pyridine derivatives as modulators of hedgehog pathway |
| 09/17/2008 | EP1970375A1 Arylmethylene urea derivative and use thereof |
| 09/17/2008 | EP1968988A1 Process for preparing unsaturated imidoalkoxysilanes |
| 09/17/2008 | EP1968981A2 A method of treating tumors with azaxanthones |
| 09/17/2008 | EP1638978A4 7-substituted camptothecin and camptothecin analogs and methods for preparing same |
| 09/17/2008 | EP1325910B1 Aliphatic nitrogenous five-membered ring compounds |
| 09/17/2008 | CN100418970C Method for preparing polymorphism of irinotecan hydrochloride |
| 09/17/2008 | CN100418950C Process for the manufacture of quinoline derivatives |
| 09/16/2008 | US7425629 Stereoselective synthesis of certain trifluoromethyl-substituted alcohols |
| 09/16/2008 | US7425575 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
| 09/16/2008 | US7425562 Inhibitors of cruzipain and other cysteine proteases |
| 09/16/2008 | US7425553 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases |
| 09/16/2008 | CA2427221C Process and intermediates for preparing anti-cancer compounds |
| 09/12/2008 | WO2008109829A1 Cyclopamine lactam analogs and methods of use thereof |
| 09/12/2008 | WO2008109614A1 9-chloro noscapine and its use in treating cancers, including drug-resistant cancers |
| 09/12/2008 | WO2008109609A1 Noscapine analogs and their use in treating cancers, including drug-resistant cancers |
| 09/12/2008 | WO2008109184A1 Heterocyclic cyclopamine analogs and methods of use thereof |
| 09/12/2008 | WO2008089453A3 Inhibitors of d-amino acid oxidase |
| 09/12/2008 | WO2004078116A9 P38 inhibitors and methods of use thereof |
| 09/12/2008 | CA2680186A1 Heterocyclic cyclopamine analogs and methods of use thereof |
| 09/12/2008 | CA2679845A1 Cyclopamine lactam analogs and methods of use thereof |
| 09/11/2008 | US20080216606 Grinding to uniform particle size; heating; pressurization;; extraction from ores, concentrates |
| 09/10/2008 | EP1966218A1 Novel, cyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 09/10/2008 | EP1966217A1 Novel, acyclic substituted furopyrimidine derivatives and use thereof for treating cardiovascular diseases |
| 09/10/2008 | EP1966134A1 Novel fused pyrrole derivatives |
| 09/10/2008 | EP1965807A2 S1p receptor modulating compounds and use thereof |
| 09/10/2008 | EP1965794A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 09/10/2008 | EP1349861B1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 09/10/2008 | EP1323710B1 Nitrogenous five-membered ring compounds |
| 09/10/2008 | CN101263144A New pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives |
| 09/09/2008 | US7423152 Process for the manufacture of intermediates in camptothecin production |
| 09/09/2008 | US7423058 Inhibitors of hepatitis C virus NS3 protease |
| 09/09/2008 | US7423048 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-(1-((2,3-dihydro(1,4)dioxino(2,3-b)pyridin-3-yl)methyl) -4- piperidinyl)-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release |
| 09/09/2008 | US7423045 e.g. amino(4-methoxy-7,7-dimethyl(7,12,12a,6a-tetrahydrochromano[4,3-b]quinolin-9-yl))methane-1-thione; increasing cellular ATP binding cassette transporter ABCA1 production ; reduces cholesterol deposition in coronary arteries; coronary artery diseases, dyslipidiemias and metabolic syndrome |
| 09/04/2008 | WO2008104175A2 Novel phosphodiesterase inhibitors |
| 09/04/2008 | US20080214819 Using an isoquinoline compound; alkylation of benzonitrile; reduction ofnitrile to an amine; cyclization |
| 09/04/2008 | US20080214817 Process for preparing n-alkylnaltrexone halides |
| 09/04/2008 | US20080214811 Xanthene dyes |
| 09/04/2008 | US20080214643 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/04/2008 | US20080214576 Topoisomerase Inhibitors and Prodrugs |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/04/2008 | CA2676933A1 Novel phosphodiesterase inhibitors |
| 09/03/2008 | EP1963334A1 Chromone derivatives useful as antagonists of vr1 receptors |
| 09/03/2008 | EP1963299A1 Oxaphenanthrene derivatives |
| 09/03/2008 | EP1963281A2 Heterocyclic derivatives as modulators of ion channels |
| 09/03/2008 | EP1670840B1 Process for making amide acetals |
| 09/03/2008 | EP1636217B1 2-imidazo-benzothiazoles as adenosine receptor ligands |
| 09/03/2008 | CN101258157A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 09/03/2008 | CN101258130A Isoquinolines as igf-1r inhibitors |
| 09/03/2008 | CN101255164A Residual current circuit breaker fused dihydropyrans and uses thereof |
| 09/03/2008 | CN101255134A Aryl pyridine compounds and medicament uses thereof |
| 09/03/2008 | CN101255132A 6-aryl-3-substituted methylene-pyridinone derivatives and uses thereof |
| 09/03/2008 | CN101255117A Non-steroidal antiphlogiston prodrug with nitric oxide donor and preparation method thereof |
| 09/02/2008 | US7420059 HMG-CoA reductase inhibitors and method |
| 09/02/2008 | US7420001 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis |
| 09/02/2008 | US7419986 Antidepressant azaheterocyclylmethyl derivatives of heterocycle-fused benzodioxans |
| 09/02/2008 | US7419985 reuptake of norephinephrine, dopamine, and serotonin inhibitor; furo-, pyrrolo-, and thienyl-tetrahydroisoquinolines, e.g. 2 methyl 4 phenyl 1,2,3,4,8,9 hexahydro furo[2,3 h]isoquinoline; antidepressant, anxiolytic agent; neurological and psychological disorders |
| 09/02/2008 | US7419969 N-((hetero)arylalkyl)pyrimidonecarboxamides in which the ring is fused to a C4-7(hetero)cycloalkyl ring, which in turn has a spiro ring attached: e.g., N-[(4-fluorophenyl)methyl]-7',8'-dihydro-3'-hydroxy-8'-methyl-4'-oxo-spiro[cyclopentane-1,9'(6'H)-[4H]pyrazino[1,2-a]pyrimidine]-2'-carboxamide |
| 09/02/2008 | US7419727 Organic electroluminescent device |
| 09/02/2008 | CA2294351C Compounds useful for inhibition of farnesyl protein transferase |
| 09/02/2008 | CA2230826C Galanthamine derivatives and process for their preparation |
| 08/28/2008 | WO2008103353A1 Triazole compounds that modulate hsp90 activity |
| 08/28/2008 | WO2008103126A1 Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008101660A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | WO2008101659A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | WO2008101266A1 Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6h-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof |
| 08/28/2008 | WO2008073785A3 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 08/28/2008 | WO2008071766A3 Spiro-indene substituted imidazonaphythyridine and pyranoimidazopyridine derivatives as inhibitors of gastric acid secretion |
| 08/28/2008 | DE102007009319A1 Spirocyclische Cyclohexan-Derivate Spirocyclic cyclohexane derivatives |
| 08/28/2008 | CA2679173A1 Spirocyclic cyclohexane derivatives |
| 08/28/2008 | CA2679166A1 Spirocyclic cyclohexane derivatives |